Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Jürgen Schumacher


Dr. Jürgen Schumacher is a Co-Founder of Algiax Pharmaceuticals and serves as its Advisor. Jürgen Schumacher is one of Germany's leading biotech entrepreneurs with more than 20 years' experience in the industry. He sits on the boards of many companies but mostly those involved in the biotech industry. Jürgen was co-founder of Qiagen and acted as spokesperson for the board. He has founded many companies in Germany including NewLab BioQuality which was recently sold to a large US company. Moreover, he is a member of numerous biotech associations and is a consultant for the biotechnology activities in North Rhine Westphalia. He also serves as the CEO of SCT Spinal Cord Therapeutics.

Primary Investor Type
Angel (individual)
Primary Office
  • Max-Planck-Str. 15a
  • 40699 Erkrath
  • Germany

+49 0211 0000000

Jürgen Schumacher Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Numaferm 11-May-2017 Seed Round Discovery Tools (Healthcare) Generating Revenue 0ü0000 0000000000
000000000 29-Nov-2016 00000 00000 00.00 Drug Discovery Generating Revenue 0ü0000 0000000000
000000 0000000 01-Oct-2015 0000 00000 Biotechnology Generating Revenue 0ü0000 0000000000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Jürgen Schumacher’s full profile, request a free trial.

Jürgen Schumacher Team (1)

Name Title Deals Funds Boards Office Contact
Jürgen Schumacher Angel Investor 0 Erkrath, Germany